Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Prodesse's Human Metapneumovirus Assay

NEW YORK (GenomeWeb News) – Prodesse today said that it has received US Food and Drug Administration clearance to market its ProhMPV+ Assay for detecting human metapneumovirus just two months after filing its submission for the test.
According to the Milwaukee-based firm, the assay is the first real-time molecular diagnostic test for HMPV to receive FDA clearance. It also is the second of Prodesse’s family of respiratory virus assays to gain FDA clearance. The firm received FDA clearance for its ProFlu Assay last January.
Prodesse said that the assay is sold with all royalties fully paid, so labs running the test would not have to make any additional payments to patent holders.
“With new ASR guidelines being enforced by the FDA as of September 2008, it has become critically important for manufacturers to gain clearance for their products,” Prodesse CEO Tom Shannon said in a statement.
Prodesse is currently conducting clinical trials on its real-time assay for parainfluenza viruses, and is developing another assay for adenovirus.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.